Rockwell Medical, Inc. (NASDAQ:RMTI ) Q2 2025 Earnings Conference Call August 14, 2025 8:00 AM ET Company Participants Heather H. Hunter - Senior VP & Chief Corporate Affairs Officer Jesse Neri - Senior VP & CFO Mark Strobeck - President, CEO & Director Conference Call Participants Jeremy Pearlman - Maxim Group LLC, Research Division Raghuram Selvaraju - H.C.
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces financial and operational results for the three and six months ended June 30, 2025.
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the second quarter ended June 30, 2025 on Thursday, August 14, 2025.
WIXOM, Mich. & FRANKLIN, Tenn.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will supply Innovative Renal Care with high-quality hemodialysis products to streamline workflows and ensure supply chain continuity.
Rockwell Medical, Inc. (NASDAQ:RMTI ) Q1 2025 Earnings Conference Call May 12, 2025 8:00 AM ET Company Participants Heather Hunter - SVP, Chief Corporate Affairs Officer Mark Strobeck - President & CEO Jesse Neri - CFO Conference Call Participants Ram Selvaraju - H.C. Wainwright Jeremy Pearlman - Maxim Group Operator Good morning, and welcome to Rockwell Medical's First Quarter 2025 Results Con...
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces financial and operational results for the three months ended March 31, 2025.
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the first quarter ended March 31, 2025 on Monday, May 12, 2025.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.